1. Home
  2. GDTC vs SLAI Comparison

GDTC vs SLAI Comparison

Compare GDTC & SLAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

N/A

Current Price

$1.77

Market Cap

24.8M

Sector

Health Care

ML Signal

N/A

SLAI

SOLAI Limited American Depositary Shares (each representing one hundred (100) Class A Ordinary Shares)

N/A

Current Price

$1.42

Market Cap

26.1M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
GDTC
SLAI
Founded
2018
2001
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
24.8M
26.1M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
GDTC
SLAI
Price
$1.77
$1.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
135.8K
108.8K
Earning Date
01-01-0001
11-21-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$573,193.00
$24,209,000.00
Revenue This Year
$5.37
$14.32
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
63.03
N/A
52 Week Low
$1.65
$1.22
52 Week High
$4.05
$8.07

Technical Indicators

Market Signals
Indicator
GDTC
SLAI
Relative Strength Index (RSI) 40.07 N/A
Support Level $1.72 N/A
Resistance Level $1.88 N/A
Average True Range (ATR) 0.12 0.00
MACD -0.00 0.00
Stochastic Oscillator 10.33 0.00

Price Performance

Historical Comparison
GDTC
SLAI

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About SLAI SOLAI Limited American Depositary Shares (each representing one hundred (100) Class A Ordinary Shares)

SOLAI Ltd is a technology-driven cryptocurrency infrastructure company. It is expanding from its foundation in crypto mining to build a blockchain-based ecosystem spanning AI, stablecoins, and payment infrastructure, and Solana treasury and staking operations supporting use cases across institutional settlement, commerce, consumer payments, and AI-native agent transactions. The group is leveraging its blockchain and data infrastructure expertise, aiming to enhance on-chain efficiency and expand participation across Solana and other blockchain ecosystems.

Share on Social Networks: